High Court Lets Teva Drug Labeling Suit Go Ahead
The U.S. Supreme Court refused Tuesday to hear an appeal by Teva Pharmaceuticals USA Inc. and other generic-drug makers of a ruling allowing a state failure-to-warn suit to proceed, potentially paving...To view the full article, register now.
Already a subscriber? Click here to view full article